NASDAQ:TLGT - Teligent Stock Price, News, & Analysis

$0.43
-0.12 (-21.82 %)
(As of 06/18/2019 01:11 AM ET)
Today's Range
$0.42
Now: $0.43
$0.57
50-Day Range
$0.45
MA: $0.77
$0.99
52-Week Range
$0.42
Now: $0.43
$4.52
Volume1.06 million shs
Average Volume490,803 shs
Market Capitalization$23.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.67
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. The company is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.86 million
Book Value$0.34 per share

Profitability

Net Income$-36,260,000.00

Miscellaneous

Employees189
Market Cap$23.16 million
Next Earnings Date8/14/2019 (Estimated)
OptionableOptionable

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.

Teligent (NASDAQ:TLGT) Frequently Asked Questions

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

How were Teligent's earnings last quarter?

Teligent Inc (NASDAQ:TLGT) posted its quarterly earnings data on Monday, May, 6th. The company reported ($0.10) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.02. The firm had revenue of $13.12 million for the quarter, compared to analysts' expectations of $16.60 million. Teligent had a negative return on equity of 103.41% and a negative net margin of 73.56%. View Teligent's Earnings History.

When is Teligent's next earnings date?

Teligent is scheduled to release their next quarterly earnings announcement on Wednesday, August 14th 2019. View Earnings Estimates for Teligent.

What price target have analysts set for TLGT?

2 brokers have issued 12 month target prices for Teligent's stock. Their predictions range from $3.00 to $3.00. On average, they anticipate Teligent's stock price to reach $3.00 in the next year. This suggests a possible upside of 597.7% from the stock's current price. View Analyst Price Targets for Teligent.

What is the consensus analysts' recommendation for Teligent?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teligent.

Has Teligent been receiving favorable news coverage?

Media stories about TLGT stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Teligent earned a coverage optimism score of 1.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Teligent.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), Aquinox Pharmaceuticals (AQXP), TherapeuticsMD (TXMD), AbbVie (ABBV), Bausch Health Companies (BHC), General Electric (GE), Akorn (AKRX) and Ocular Therapeutix (OCUL).

Who are Teligent's key executives?

Teligent's management team includes the folowing people:
  • Mr. Jason Grenfell-Gardner M.B.A., M.B.A, Pres, CEO & Director (Age 44)
  • Mr. Stephen Richardson, Chief Scientific Officer (Age 53)
  • Mr. Martin Wilson, Gen. Counsel (Age 42)
  • Mr. Damian Finio, Corp. Sec. & CFO (Age 49)
  • Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 50)

Who are Teligent's major shareholders?

Teligent's stock is owned by many different of retail and institutional investors. Top institutional shareholders include AMI Asset Management Corp (5.07%), Sanders Morris Harris LLC (3.90%), Spark Investment Management LLC (0.42%), Private Advisors LLC (0.32%) and Private Advisors LLC (0.32%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner, Jenniffer Collins, Stephen Richardson and Steven H Koehler. View Institutional Ownership Trends for Teligent.

Which major investors are selling Teligent stock?

TLGT stock was sold by a variety of institutional investors in the last quarter, including Private Advisors LLC and Private Advisors LLC. View Insider Buying and Selling for Teligent.

Which major investors are buying Teligent stock?

TLGT stock was purchased by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC, Spark Investment Management LLC and AMI Asset Management Corp. Company insiders that have bought Teligent stock in the last two years include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner, Jenniffer Collins, Stephen Richardson and Steven H Koehler. View Insider Buying and Selling for Teligent.

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $0.43.

How big of a company is Teligent?

Teligent has a market capitalization of $23.16 million and generates $65.86 million in revenue each year. The company earns $-36,260,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis. Teligent employs 189 workers across the globe.View Additional Information About Teligent.

What is Teligent's official website?

The official website for Teligent is http://www.teligent.com/.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]


MarketBeat Community Rating for Teligent (NASDAQ TLGT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  244 (Vote Outperform)
Underperform Votes:  213 (Vote Underperform)
Total Votes:  457
MarketBeat's community ratings are surveys of what our community members think about Teligent and other stocks. Vote "Outperform" if you believe TLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel